IceCure Medical Ltd.

icecure-medical.com

Formerly Arbel Medical

High-Tech Company
Public Company

(TASE: ICCM), (NASDAQ CM: ICCM)

Graduated from: Abital

TECH VERTICALS

Breast Cancer, FemTech, Healthtech, Medical Devices, MedTech, Ultrasound, Women Health

General Data

Sector

Medical Devices

TECHNOLOGY

Based on liquid nitrogen, IceCure’s proprietary third-generation technology generates lower tissue temperatures and a faster cooling rate than other methods, to enable a larger ice-ball tumor killing area for maximum efficacy.

CONTACT INFO

Personal Contact Information

Blog

Expand / Collapse All

	MANAGEMENT

Key Executive

	BOARD

Board

	FINANCIAL ROUNDS

Round

Date

Stage

Amount

Valuation

PIPE

Jan. 28, 2021

Initial Revenues

$15m

N/A

General Info

Angel Company & Title
E-mail
Website
No. of Current Portfolio Companies
Remarks

Business Description

Description
Angel Activity

Investment Data

Managed Capital
Capital Remarks
Capital Available

Preferences

Maximum investments
Minimum investments
Type of Financing
Stage Preferences
Phase Preferences
Industry Preferences

	SECTOR SEGMENTATION (By Number Of Companies)

Current Israeli Clients (#)

	Deals Underwritten (#)

	Deals Legally Advised (#)

	Current Positions

	Previous Positions

	Background

	Education

	Specialties

Last Updated:	Jul 14, 2025
IVC Number:	A1000000005970